Cell therapy Archives

tigenix takeda stem cell therapy crohns fistula

News and Trends 6 Jul 2016

Takeda snatches up Belgian Cell therapy for Crohn’s Disease

TiGenix is licensing the rights for its cell therapy which is under EMA review and is meant to treat a serious complication of Crohn's disease. This worldwide exclusivity deal (with…

July 6, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 30 Jun 2016

Key German Hospital to start a Phase I trial in TCR Cell Therapy

Medigene will make its clinical debut in TCR, in a collaboration with the Max Delbrück Centre and the Charité Hospital in Berlin. The planned Phase I trial focus on the…

June 30, 2016 - 3 minutesmins - By Denise Neves Gameiro

celyad c cure chart1 ischemic heart failure

News and Trends 29 Jun 2016

Cell Therapy for Heart Failure fails in Phase III … but not Entirely

Celyad failed to get significant results in its Phase III trial in cardiac disease. However, this cell therapy could still have a positive effect in a part of the patients. True…

June 29, 2016 - 3 minutesmins - By Denise Neves Gameiro

molmed graft host disease zalmoxis leukemia

News and Trends 28 Jun 2016

Will the Leading Italian Biotech soon have its First Cell therapy on the Market?

MolMed has received conditional market approval for Zalmoxis, an ex vivo genetically engineered cell therapy that stops immune rejection of transplanted hematopoietic stem cells. This is a big step forward in a key…

June 28, 2016 - 2 minutesmins - By Denise Neves Gameiro

diabetes glucose chronic disease biotech pharma review

News and Trends 14 Jun 2016

Could this be the ‘Beginning of the end’ for Diabetes? Let’s Review.

Given the rates of diabetes reaching 'epidemic proportions', we figured it was time to have a better overview of biotech's progress in the field. With some serious advances having been…

June 14, 2016 - 9 minutesmins - By Dani Bancroft

News and Trends 13 Jun 2016

Immunotherapy reaches Breakthrough in eliminating HIV

Immunocore has published key results for its new preclinical candidate for HIV, ImmTAV. This TCR-based immunotherapy has succeeded in targeting T-cells where HIV infection often 'hides' from drugs. Just after…

June 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

crispr therapeutics muscle stem cells anagenesis

News and Trends 10 Jun 2016

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

CRISPR Therapeutics has struck a deal with Anagenesis Biotechnologies, which has key technology for muscle stem cells. Together, they will tackle muscle disorders - including the rare disease Duchenne Muscular Dystrophy…

June 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

huntingtons rochester copenhagen glia transplant

News and Trends 9 Jun 2016

Brain Cell Transplant could help with incurable Neurodegenerative Disease

Researchers from Copenhagen and the US have succeeded in slowing the progression of Huntington's disease in mice with a transplant of healthy human brain cells. This provides a new route to…

June 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

bone therapeutics allob allogeneic osteoporosis

News and Trends 19 May 2016

Bone Therapeutics switches to allogeneic for Universal Bone Cell Therapy

Bone Therapeutics is moving forward with a new phase II trial targeting severe osteroporosis - but this time with its allogeneic bone cell therapy (ALLOB). This type of therapy is…

May 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 8 Apr 2016

Biotech of the Week: Activartis Immuno-Oncology in Vienna

This week, we leave Milan and head once again towards the East. Vienna: Austria's palatial and stunning capital city is our destination, and is also where our Biotech of the…

April 8, 2016 - 1 minutemin - By Joachim Eeckhout

News and Trends 30 Mar 2016

Dutch Startup gets €7M for New Cancer Immunotherapy Platform

Gadeta has raised €7M in a series A round, which will fuel the clinical development of its novel TCR platform, starting with a leukemia cell therapy trial. Gadeta is a…

March 30, 2016 - 2 minutesmins - By Denise Neves Gameiro

gsk miltenyi biotech gmp cell gene therapy tcr car t

News and Trends 17 Mar 2016

GSK partners to Scale Manufacturing of CAR-T Therapies

Production of CAR-T therapies seems to be one of the biggest challenge of this promising technology. Miltenyi Biotec (Germany) and GSK have entered a new partnership to combine the clinical development of cell…

March 17, 2016 - 3 minutesmins - By Denise Neves Gameiro

bone therapeutics allob preob spine therapy medtech

News and Trends 18 Feb 2016

This Bone Cell Therapy Could Make it to a Shelf Near You

Bone Therapeutics (Belgium) is almost finished with the phase IIa trial for a Spinal cell therapy. The 12 people treated for degenerative bone conditions show no complications - a gold star…

February 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

cambridge gsk ucl imperial apollo jj astrazeneca

News and Trends 27 Jan 2016

New UK Joint Venture Bridges Gap between Top Universities and Big Pharmas

AstraZeneca, GlaxoSmithKline, Johnson & Johnson and the 3 world-leading universities (Imperial College London, University College London and the University of Cambridge) have joined forces to found the 'Apollo' Bridge. This…

January 27, 2016 - 3 minutesmins - By Dani Bancroft

roche cellsqueeze sqz cell therapies Cancer

News and Trends 9 Dec 2015

Squeezing Cells: A Revolutionary Cancer Drug Delivery Platform for €455M?

The MIT spin-off SQZ Biotech has an invention (Cell SQueeZe) which could make vector drug delivery in Cancer a thing of the past... Roche thinks so too, and has now acquired…

December 9, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 27 Nov 2015

Could this new TCR Lung Cancer Trial Save Adaptimmune from a Volatile Stock Situation?

Adaptimmune has initiated a phase I/II safety and tolerability study of its affinity enhanced T-cell therapy targeting the NY-ESO-1 cancer antigen in patients with non-small cell lung cancer (NSCLC). Adaptimmune…

November 27, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 19 Nov 2015

“The Next Generation of Biologicals will be Cell-based”

That's what Zami Aberman, CEO of one of the world-leading cell-therapy company Pluristem told me during our lunch at Berlin this week. An enthusiastic statement for a sector that could indeed be…

November 19, 2015 - 6 minutesmins - By Philip Hemme

News and Trends 14 Nov 2015

What happened this week? mRNA Therapies, TCR & Algae Beer

Monday: Leading TCR Immuno-oncology Biotech shows Promising Results against Cancer Tuesday: What the FUGT? We tried the Algae Bar Beer for the TransArt Fest in Copenhagen! Wednesday: Using Algae and NanoTech…

November 14, 2015 - 1 minutemin - By Philip Hemme

News and Trends 9 Nov 2015

Leading TCR Immuno-oncology Biotech shows Promising Results against Cancer

Cell-based Immune-oncology therapies continue to deliver amazing results. After Cellectis wondersaving from last week, Oxford's Adaptimmune has some surprisingly good results too. Adaptimmune is a British, Oxford-based immuno-oncolgy company. It…

November 9, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 4 Nov 2015

€1.37Bn Deal for Sanofi with Germany’s Fastest Growing mRNA Cancer Biotech

Sanofi is now the latest Biotech lining up to partner with BioNTech from Mainz (Germany), for license of their mRNA Immuno-oncology platform in a€1.37Bn long-term development deal. Novel mRNA targets…

November 4, 2015 - 3 minutesmins - By Dani Bancroft

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering